Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Transplant Infection”

305 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 305 results

Not applicableStudy completedNCT02125071
What this trial is testing

Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation

Who this might be right for
Liver CirrhosisChronic Hepatitis B
Dong-Gu Kim 20
Post-approval studies (Phase 4)WithdrawnNCT03315052
What this trial is testing

Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

Who this might be right for
Acute Cellular Graft RejectionLiver Transplant Rejection
Montefiore Medical Center
Large-scale testing (Phase 3)Study completedNCT01131065
What this trial is testing

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Who this might be right for
Hepatitis BLiver Transplantation
Instituto Grifols, S.A. 15
Not applicableLooking for participantsNCT04493385
What this trial is testing

The Hepatitis C Transplant Collaborative

Who this might be right for
Transplant; Failure, HeartHepatitis C
Baylor Research Institute 500
Large-scale testing (Phase 3)UnknownNCT03402776
What this trial is testing

Impact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell Transplantation

Who this might be right for
Haemopoietic Stem Cell TransplantationAllograft
University Hospital, Grenoble 200
Testing effectiveness (Phase 2)Ended earlyNCT00582738
What this trial is testing

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

Who this might be right for
Recurrent Hepatitis C
Novartis Pharmaceuticals 43
Post-approval studies (Phase 4)Ended earlyNCT03207399
What this trial is testing

Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment

Who this might be right for
Hepatitis C, ChronicLung Transplant
Duke University 1
Post-approval studies (Phase 4)UnknownNCT01770119
What this trial is testing

Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients

Who this might be right for
Measles
Klara M. Pósfay Barbe 90
Testing effectiveness (Phase 2)Study completedNCT02781571
What this trial is testing

Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 79
Post-approval studies (Phase 4)Study completedNCT02631772
What this trial is testing

LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients

Who this might be right for
Hepatitis C
Medical University of South Carolina 32
Large-scale testing (Phase 3)Study completedNCT02966795
What this trial is testing

Of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 84
Post-approval studies (Phase 4)Looking for participantsNCT07189377
What this trial is testing

Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

Who this might be right for
Hepatitis B Virus (HBV)Lung Transplant Recipient
University Health Network, Toronto 20
Post-approval studies (Phase 4)Study completedNCT00275548
What this trial is testing

Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C

Who this might be right for
Liver TransplantHepatitis C
Mayo Clinic 12
Not applicableStudy completedNCT01859884
What this trial is testing

Optimizing Kidney Transplant Informed Consent

Who this might be right for
End-stage Kidney Disease
Northwestern University 288
Large-scale testing (Phase 3)Study completedNCT01707849
What this trial is testing

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Who this might be right for
Hepatitis C Recurrence After Liver Transplant
Hospital Vall d'Hebron 18
Not applicableUnknownNCT05109156
What this trial is testing

Preoperative Sepsis Timeline, Profile and Its Association With Recipient Outcome Following Live Donor Liver Transplant

Who this might be right for
SepsisLiver Transplant; Complications
Institute of Liver and Biliary Sciences, India 500
Testing effectiveness (Phase 2)Study completedNCT01685372
What this trial is testing

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

Who this might be right for
Solid Organ Transplant Recipient (Liver, Kidney, Heart)Rheumatologic DisorderHuman Immunodeficiency Virus (HIV)+2 more
University of Colorado, Denver 16
Post-approval studies (Phase 4)Study completedNCT00383864
What this trial is testing

Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.

Who this might be right for
Hepatitis C
Hospital Clinic of Barcelona 55
Not applicableStudy completedNCT03880682
What this trial is testing

Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant; ComplicationsHepatitis C, Chronic
Istanbul University 30
Large-scale testing (Phase 3)Study completedNCT02639247
What this trial is testing

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 333
Load More Results